Karyn I. Morgan
ii ii
TEST BANK-
Davis Advantage for Psychiatric Mental Health
th
Nursing 11 Edition
ii
, Tableiiofii Contents
Chapterii01.iiTheiiConceptiiofiiStressiiAdaptation
Chapterii02.iiMentaliiHealth/MentaliiIllness:iiHistoricaliiandiiTheoreticaliiConceptsiiC
hapterii03.iiPsychopharmacology
Chapterii04.iiConceptsiiofiiPsychobiology
Chapterii05.iiEthicaliiandiiLegaliiIssuesiiiniiPsychiatric/MentaliiHealthiiNursing
Chapterii06.iiCulturaliiandiiSpiritualiiConceptsiiRelevantiitoiiPsychiatric/MentaliiHealthiiNursingiiChapt
erii07.iiRelationshipiiDevelopment
Chapterii08.iiTherapeuticiiCommunication
Chapterii09.iiTheiiNursingiiProcessiiiniiPsychiatric/MentaliiHealthiiNursingiiChapterii
10.iiTherapeuticiiGroups
Chapterii11.iiInterventioniiWithiiFamilies
Chapterii12.iiMilieuiiTherapyii-
iiTheiiTherapeuticiiCommunityiiChapterii13.iiCrisisiiIntervention
Chapterii14.iiAssertivenessiiTrainingiiChapt
erii15.iiPromotingiiSelf-Esteem
Chapteri16.iAnger/AggressioniManagementiiChapt
erii17.iiTheiiSuicidaliiClient
Chapterii18.iiBehaviori i TherapyiiChapte
rii19.iiCognitivei i TherapyiiChapteri20.iEl
ectroconvulsiveiTherapyiiChapterii21.iiT
heiiRecoveryiiModeliiChapterii22.iiNeuro
cognitiveiiDisorders
Chapterii23.iiSubstance-RelatediiandiiAddictiveii Disorders
Chapterii24.iiSchizophreniaiiSpectrumiiandiiOtheriiPsychoticiiDisordersiiChapterii
25.iiDepressiveiiDisorders
Chapterii26.iiBipolariiandiiRelatediiDisorders
Chapterii27.iiAnxiety,iiObsessive-
Compulsive,iiandiiRelatediiDisordersiiChapterii28:iiTraumaiiandiiStressor-
RelatediiDisorders
Chapterii29.ii SomaticiiSymptomii andiiDissociativeiiDisorders
Chapterii30.iiIssuesiiRelatediitoiiHumaniiSexualityiiandiiGenderiiDysphoriaiiChapterii
31.iiEatingiiDisorders
Chapterii32.iiPersonalityiiDisordersiiChapte
ri33.iChildreniandiAdolescentsiiChapterii34.ii
TheiiAgingiiIndividual
Chapterii35.iiSurvivorsiiofiiAbuseiioriiNeglectiiChapterii
36.iiCommunityiiMentaliiHealthiiNursingiiChapterii37.ii
TheiiBereavediiIndividual
Chapterii38.iiMilitaryiiFamilies
,Chapter 01. Psychopharmacology
ii ii
MultipleiiChoice
1. TheiiNURSEiimanageriioniitheiipsychiatriciiunitiiwasiiexplainingiitoiitheiinewiistaffiitheiidifferencesiibetweeni
itypicaliiandiiatypicaliiantipsychotics.iiTheiiNURSEiicorrectlyiistatesiithatiiatypicaliiantipsychotics:
A. Remainiiiniitheiisystemiilonger
B. Actiimoreiiquicklyiitoiireduceiidelusions
C. Produceiifeweriiextrapyramidaliieffects
D. Areiiriskiifreeiiforiineurolepticiimalignantiisyndromeii(NMS)
CORRECTiiANSWER:C
AtypicaliiantipsychoticsiiproduceiilessiiD2blockade;iithusiimovementiidisordersiiareiilessiiofiiaiiproblem.iiNoiievidenceiis
uggestsiithatiitheiimedicationiiremainsiiiniitheiisystemiilongeriinoriithatiiitiiactsiimoreiiquicklytoiireduceiidelusions.iiTheiiaty
picalsiiareiinotiiriskiifreeiiforiiNMS.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiImplementationii |iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
2. TheiiNURSEiiwouldiiassessiiforiineurolepticiimalignantiisyndromeii(NMS)iiifiiaiipatientiioniihaloperidoli
i(Haldol)iidevelopsiia:
A. 30iimmiiHgiidecreaseiiiniibloodiipressureiireading
B. Respiratoryiirateiiofii24iirespirationsiiperiiminute
C. Temperatureiireadingi i ofii104°i i F
D. Pulseiirateiiofii70iibeatsiiperiiminute
CORRECTiiANSWER:C
IncreasediitemperatureiiisiitheiicardinaliisigniiofiiNMS.iiThisiiBPiiisiinotiiaiisignificantiifeatureiiofiiNMS.iiThereiiareiinoiisignifi
cantiifindingsiitoiisupportiitheiioptionsiirelatediitoiirespirationsiioriipulseiirate.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
3. Aiipatientiitakingiifluphenazineii(Prolixin)iicomplainsiiofiidryiimouthiiandiiblurrediivision.iiWhatiiwouldiitheiiNURSE
iiassessiiasiitheiilikelyiicauseiiofiitheseiisymptoms?
A. Decreasediidopamineiiatiireceptoriisites
B. Blockadeiiofiihistamine
C. Cholinergiciiblockade
D. Adrenergiciiblocking
CORRECTiiANSWER:C
Fluphenazineiiadministrationiiproducesiiblockadeiiofiicholinergiciireceptorsiigivingiiriseiitoiianticholinergiciieffects,iisu
chiiasiidryiimouth,iiblurrediivision,iiandiiconstipation.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
, 4. Whichiibehavioriidisplayediibyiiaiipatientiireceivingiiaiitypicaliiantipsychoticiimedicationiiwouldiibeiiassessediiasi
idisplayingiibehaviorsiicharacteristiciiofiitardiveiidyskinesiaii(TD)?
A. Grimacingiiandiilipiismacking
B. Fallingiiasleepiiiniitheiichairiiandiirefusingiitoiieatiilunch
C. Experiencingiimuscleiirigidityiiandiitremors
D. Havingiiexcessiveiisalivationiiandiidrooling
CORRECTiiANSWER:A
TDi i manifestsi i asi i abnormali i movementsi i ofi i voluntaryi i musclei i groupsi i afteri i ai i prolongedi i periodi i ofi i dopami
neiiblockade.i i Movementsi i mayi i affecti i anyi i musclei i group,i i buti i musclesi i ofiithei i face,i i mouth,i i tongue,i i andiidigitsiia
reiicommonlyiiaffected.iiFallingiiasleepiiisiireflectiveiiofiitheiisedativeiieffectiiofiitheseiimedications.iiMuscleiirigidityiiandiid
roolingi i reflecti i EPSi i causedi i fromi i imbalancei i betweeni i dopaminei i andi i acetylcholine.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
5. AiiNURSEiiadministersiiaiimedicationiithatiipotentiatesiitheiiactioniiofiiGABA.iiWhichiifindingiiwouldiibeiiexpected?
A. Reducediianxiety
B. Improvedii memory
C. Moreiiorganizediithinking
D. Feweriisensoryiiperceptualiialterations
CORRECTiiANSWER:A
IncreasediilevelsiiofiiGABAiireduceiianxiety,iithusiianyiipotentiationiiofiiGABAiiactioniishouldiiresultiiiniianxietyiired
uction.iiMemoryiienhancementiiisiiassociatediiwithiiacetylcholineiiandiisubstanceiiP.iiThoughtiidisorganizationiiisiias
sociatedi i withi i dopamine.i i GABAi i isi i noti i associatedi i withi i sensoryi i perceptuali i alterations.
KEY:iiCognitiveiiLevel:iiApplicationii|iiIntegratediiProcesses:iiNursingiiProcess:iiEvaluationii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
6. Oniitheiibasisiiofiicurrentiiknowledgeiiofiineurotransmitteriieffects,iiaiiNURSEiicouldiianticipateiithatiithei
itreatmentiiplani i foriiai i patientiiwithi i memoryi i difficultiesiimightiiincludei i medicationsiidesignediito:
A. inhibitiiGABA.
B. increaseiidopamineiiatiireceptoriisites.
C. decreaseiidopamineiiatiireceptoriisites.
D. preventiidestructioniiofiiacetylcholine.
CORRECTiiANSWER:D
Increasedi i acetylcholinei i playsi i ai i rolei i ini i learningi i andi i memory.i i Preventingi i destructioni i ofi i acetylcholinei i b
yiiacetylcholinesterasei i wouldi i resultiiiniihigheriilevelsiiofiiacetylcholine,iiwithi i theiipotentiali i foriiimprovedi i memory.iiG
ABAi i isi i knowni i toi i affecti i anxietyi i leveli i ratheri i thani i memory.i i Increasedi i dopaminei i wouldi i causei i symptom
siiassociatediiwithiischizophreniaiioriimaniaiiratheriithaniiimproveiimemory.iiDecreasingiidopamineiiatiireceptoriisitesiiisiiass
ociatedi i withi i Parkinson’si i diseasei i ratheri i thani i improvingi i memory.
KEY:iiCognitiveiiLevel:iiComprehensionii |iiIntegratediiProcesses:iiNursingiiProcess:iiPlanningii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
ii ii
TEST BANK-
Davis Advantage for Psychiatric Mental Health
th
Nursing 11 Edition
ii
, Tableiiofii Contents
Chapterii01.iiTheiiConceptiiofiiStressiiAdaptation
Chapterii02.iiMentaliiHealth/MentaliiIllness:iiHistoricaliiandiiTheoreticaliiConceptsiiC
hapterii03.iiPsychopharmacology
Chapterii04.iiConceptsiiofiiPsychobiology
Chapterii05.iiEthicaliiandiiLegaliiIssuesiiiniiPsychiatric/MentaliiHealthiiNursing
Chapterii06.iiCulturaliiandiiSpiritualiiConceptsiiRelevantiitoiiPsychiatric/MentaliiHealthiiNursingiiChapt
erii07.iiRelationshipiiDevelopment
Chapterii08.iiTherapeuticiiCommunication
Chapterii09.iiTheiiNursingiiProcessiiiniiPsychiatric/MentaliiHealthiiNursingiiChapterii
10.iiTherapeuticiiGroups
Chapterii11.iiInterventioniiWithiiFamilies
Chapterii12.iiMilieuiiTherapyii-
iiTheiiTherapeuticiiCommunityiiChapterii13.iiCrisisiiIntervention
Chapterii14.iiAssertivenessiiTrainingiiChapt
erii15.iiPromotingiiSelf-Esteem
Chapteri16.iAnger/AggressioniManagementiiChapt
erii17.iiTheiiSuicidaliiClient
Chapterii18.iiBehaviori i TherapyiiChapte
rii19.iiCognitivei i TherapyiiChapteri20.iEl
ectroconvulsiveiTherapyiiChapterii21.iiT
heiiRecoveryiiModeliiChapterii22.iiNeuro
cognitiveiiDisorders
Chapterii23.iiSubstance-RelatediiandiiAddictiveii Disorders
Chapterii24.iiSchizophreniaiiSpectrumiiandiiOtheriiPsychoticiiDisordersiiChapterii
25.iiDepressiveiiDisorders
Chapterii26.iiBipolariiandiiRelatediiDisorders
Chapterii27.iiAnxiety,iiObsessive-
Compulsive,iiandiiRelatediiDisordersiiChapterii28:iiTraumaiiandiiStressor-
RelatediiDisorders
Chapterii29.ii SomaticiiSymptomii andiiDissociativeiiDisorders
Chapterii30.iiIssuesiiRelatediitoiiHumaniiSexualityiiandiiGenderiiDysphoriaiiChapterii
31.iiEatingiiDisorders
Chapterii32.iiPersonalityiiDisordersiiChapte
ri33.iChildreniandiAdolescentsiiChapterii34.ii
TheiiAgingiiIndividual
Chapterii35.iiSurvivorsiiofiiAbuseiioriiNeglectiiChapterii
36.iiCommunityiiMentaliiHealthiiNursingiiChapterii37.ii
TheiiBereavediiIndividual
Chapterii38.iiMilitaryiiFamilies
,Chapter 01. Psychopharmacology
ii ii
MultipleiiChoice
1. TheiiNURSEiimanageriioniitheiipsychiatriciiunitiiwasiiexplainingiitoiitheiinewiistaffiitheiidifferencesiibetweeni
itypicaliiandiiatypicaliiantipsychotics.iiTheiiNURSEiicorrectlyiistatesiithatiiatypicaliiantipsychotics:
A. Remainiiiniitheiisystemiilonger
B. Actiimoreiiquicklyiitoiireduceiidelusions
C. Produceiifeweriiextrapyramidaliieffects
D. Areiiriskiifreeiiforiineurolepticiimalignantiisyndromeii(NMS)
CORRECTiiANSWER:C
AtypicaliiantipsychoticsiiproduceiilessiiD2blockade;iithusiimovementiidisordersiiareiilessiiofiiaiiproblem.iiNoiievidenceiis
uggestsiithatiitheiimedicationiiremainsiiiniitheiisystemiilongeriinoriithatiiitiiactsiimoreiiquicklytoiireduceiidelusions.iiTheiiaty
picalsiiareiinotiiriskiifreeiiforiiNMS.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiImplementationii |iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
2. TheiiNURSEiiwouldiiassessiiforiineurolepticiimalignantiisyndromeii(NMS)iiifiiaiipatientiioniihaloperidoli
i(Haldol)iidevelopsiia:
A. 30iimmiiHgiidecreaseiiiniibloodiipressureiireading
B. Respiratoryiirateiiofii24iirespirationsiiperiiminute
C. Temperatureiireadingi i ofii104°i i F
D. Pulseiirateiiofii70iibeatsiiperiiminute
CORRECTiiANSWER:C
IncreasediitemperatureiiisiitheiicardinaliisigniiofiiNMS.iiThisiiBPiiisiinotiiaiisignificantiifeatureiiofiiNMS.iiThereiiareiinoiisignifi
cantiifindingsiitoiisupportiitheiioptionsiirelatediitoiirespirationsiioriipulseiirate.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
3. Aiipatientiitakingiifluphenazineii(Prolixin)iicomplainsiiofiidryiimouthiiandiiblurrediivision.iiWhatiiwouldiitheiiNURSE
iiassessiiasiitheiilikelyiicauseiiofiitheseiisymptoms?
A. Decreasediidopamineiiatiireceptoriisites
B. Blockadeiiofiihistamine
C. Cholinergiciiblockade
D. Adrenergiciiblocking
CORRECTiiANSWER:C
Fluphenazineiiadministrationiiproducesiiblockadeiiofiicholinergiciireceptorsiigivingiiriseiitoiianticholinergiciieffects,iisu
chiiasiidryiimouth,iiblurrediivision,iiandiiconstipation.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
, 4. Whichiibehavioriidisplayediibyiiaiipatientiireceivingiiaiitypicaliiantipsychoticiimedicationiiwouldiibeiiassessediiasi
idisplayingiibehaviorsiicharacteristiciiofiitardiveiidyskinesiaii(TD)?
A. Grimacingiiandiilipiismacking
B. Fallingiiasleepiiiniitheiichairiiandiirefusingiitoiieatiilunch
C. Experiencingiimuscleiirigidityiiandiitremors
D. Havingiiexcessiveiisalivationiiandiidrooling
CORRECTiiANSWER:A
TDi i manifestsi i asi i abnormali i movementsi i ofi i voluntaryi i musclei i groupsi i afteri i ai i prolongedi i periodi i ofi i dopami
neiiblockade.i i Movementsi i mayi i affecti i anyi i musclei i group,i i buti i musclesi i ofiithei i face,i i mouth,i i tongue,i i andiidigitsiia
reiicommonlyiiaffected.iiFallingiiasleepiiisiireflectiveiiofiitheiisedativeiieffectiiofiitheseiimedications.iiMuscleiirigidityiiandiid
roolingi i reflecti i EPSi i causedi i fromi i imbalancei i betweeni i dopaminei i andi i acetylcholine.
KEY:iiCognitiveiiLevel:iiApplicationii |iiIntegratediiProcesses:iiNursingiiProcess:iiAssessmentii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
5. AiiNURSEiiadministersiiaiimedicationiithatiipotentiatesiitheiiactioniiofiiGABA.iiWhichiifindingiiwouldiibeiiexpected?
A. Reducediianxiety
B. Improvedii memory
C. Moreiiorganizediithinking
D. Feweriisensoryiiperceptualiialterations
CORRECTiiANSWER:A
IncreasediilevelsiiofiiGABAiireduceiianxiety,iithusiianyiipotentiationiiofiiGABAiiactioniishouldiiresultiiiniianxietyiired
uction.iiMemoryiienhancementiiisiiassociatediiwithiiacetylcholineiiandiisubstanceiiP.iiThoughtiidisorganizationiiisiias
sociatedi i withi i dopamine.i i GABAi i isi i noti i associatedi i withi i sensoryi i perceptuali i alterations.
KEY:iiCognitiveiiLevel:iiApplicationii|iiIntegratediiProcesses:iiNursingiiProcess:iiEvaluationii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
6. Oniitheiibasisiiofiicurrentiiknowledgeiiofiineurotransmitteriieffects,iiaiiNURSEiicouldiianticipateiithatiithei
itreatmentiiplani i foriiai i patientiiwithi i memoryi i difficultiesiimightiiincludei i medicationsiidesignediito:
A. inhibitiiGABA.
B. increaseiidopamineiiatiireceptoriisites.
C. decreaseiidopamineiiatiireceptoriisites.
D. preventiidestructioniiofiiacetylcholine.
CORRECTiiANSWER:D
Increasedi i acetylcholinei i playsi i ai i rolei i ini i learningi i andi i memory.i i Preventingi i destructioni i ofi i acetylcholinei i b
yiiacetylcholinesterasei i wouldi i resultiiiniihigheriilevelsiiofiiacetylcholine,iiwithi i theiipotentiali i foriiimprovedi i memory.iiG
ABAi i isi i knowni i toi i affecti i anxietyi i leveli i ratheri i thani i memory.i i Increasedi i dopaminei i wouldi i causei i symptom
siiassociatediiwithiischizophreniaiioriimaniaiiratheriithaniiimproveiimemory.iiDecreasingiidopamineiiatiireceptoriisitesiiisiiass
ociatedi i withi i Parkinson’si i diseasei i ratheri i thani i improvingi i memory.
KEY:iiCognitiveiiLevel:iiComprehensionii |iiIntegratediiProcesses:iiNursingiiProcess:iiPlanningii|iiClientiiNeed:
PhysiologicaliiIntegrity:iiPharmacologicaliiandiiParenteraliiTherapies
